Annual Working Capital
$327.80 M
+$41.19 M+14.37%
31 December 2023
Summary:
Sutro Biopharma annual working capital is currently $327.80 million, with the most recent change of +$41.19 million (+14.37%) on 31 December 2023. During the last 3 years, it has risen by +$151.02 million (+85.43%). STRO annual working capital is now -5.96% below its all-time high of $348.58 million, reached on 31 December 2020.STRO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$274.49 M
-$39.00 M-12.44%
30 September 2024
Summary:
Sutro Biopharma quarterly working capital is currently $274.49 million, with the most recent change of -$39.00 million (-12.44%) on 30 September 2024. Over the past year, it has dropped by -$53.31 million (-16.26%). STRO quarterly working capital is now -21.26% below its all-time high of $348.58 million, reached on 31 December 2020.STRO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STRO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -16.3% |
| 3 y3 years | +85.4% | +55.3% |
| 5 y5 years | +242.9% | +187.1% |
STRO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +85.4% | -20.4% | +55.3% |
| 5 y | 5 years | -6.0% | +242.9% | -21.3% | +187.6% |
| alltime | all time | -6.0% | +5280.9% | -21.3% | +4438.4% |
Sutro Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $274.49 M(-12.4%) |
| June 2024 | - | $313.49 M(+14.0%) |
| Mar 2024 | - | $275.07 M(-16.1%) |
| Dec 2023 | $327.80 M(+14.4%) | $327.80 M(+6.5%) |
| Sept 2023 | - | $307.65 M(-10.8%) |
| June 2023 | - | $344.86 M(+41.0%) |
| Mar 2023 | - | $244.58 M(-14.7%) |
| Dec 2022 | $286.61 M(+62.1%) | $286.61 M(-0.6%) |
| Sept 2022 | - | $288.26 M(+0.5%) |
| June 2022 | - | $286.94 M(+51.0%) |
| Mar 2022 | - | $189.98 M(+7.5%) |
| Dec 2021 | $176.78 M | $176.78 M(-17.9%) |
| Sept 2021 | - | $215.27 M(-14.4%) |
| June 2021 | - | $251.49 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $243.34 M(-30.2%) |
| Dec 2020 | $348.58 M(+264.6%) | $348.58 M(+32.9%) |
| Sept 2020 | - | $262.39 M(+17.6%) |
| June 2020 | - | $223.03 M(+133.7%) |
| Mar 2020 | - | $95.45 M(-0.2%) |
| Dec 2019 | $95.60 M(-44.9%) | $95.60 M(-4.1%) |
| Sept 2019 | - | $99.71 M(-20.9%) |
| June 2019 | - | $126.12 M(-13.3%) |
| Mar 2019 | - | $145.41 M(-16.2%) |
| Dec 2018 | $173.52 M(-2842.6%) | $173.52 M(+91.8%) |
| Sept 2018 | - | $90.47 M(+722.7%) |
| June 2018 | - | $11.00 M(-273.8%) |
| Dec 2017 | -$6.33 M(+1183.4%) | -$6.33 M |
| Dec 2016 | -$493.00 K | - |
FAQ
- What is Sutro Biopharma annual working capital?
- What is the all time high annual working capital for Sutro Biopharma?
- What is Sutro Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Sutro Biopharma?
- What is Sutro Biopharma quarterly working capital year-on-year change?
What is Sutro Biopharma annual working capital?
The current annual working capital of STRO is $327.80 M
What is the all time high annual working capital for Sutro Biopharma?
Sutro Biopharma all-time high annual working capital is $348.58 M
What is Sutro Biopharma quarterly working capital?
The current quarterly working capital of STRO is $274.49 M
What is the all time high quarterly working capital for Sutro Biopharma?
Sutro Biopharma all-time high quarterly working capital is $348.58 M
What is Sutro Biopharma quarterly working capital year-on-year change?
Over the past year, STRO quarterly working capital has changed by -$53.31 M (-16.26%)